Immix Biopharma
IMMX
IMMX
8 hedge funds and large institutions have $352K invested in Immix Biopharma in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, 1 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
8
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$151K | |
| 2 | +$57K | |
| 3 | +$38K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$31K |
| 5 |
BlackRock
New York
|
+$22K |
Top Sellers
| 1 | -$2.48M | |
| 2 | -$2.01M | |
| 3 | -$436K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$116K |
| 5 |
EVC
Eidelman Virant Capital
Saint Louis,
Missouri
|
-$103K |